Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology.

Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology.

Item
http://www.wikidata.org/entity/Q37834466
Profile of adalimumab and its potential in the treatment of uveitisEfficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case seriesSuccess with single-agent immunosuppression for multifocal choroidopathies.Increased CD1c+ mDC1 with mature phenotype regulated by TNFα-p38 MAPK in autoimmune ocular inflammatory diseaseIntestinal Behçet's disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis.New options for uveitis treatment.Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis.Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions.Biologic agents in experimental autoimmune uveitis.Infliximab for peripheral ulcerative keratitis treatment.Effect of the Toll-like receptor 4 antagonist eritoran on retinochoroidal inflammatory damage in a rat model of endotoxin-induced inflammation.Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behçet's disease responding to infliximab.Psoriatic uveitis responding to adalimumab therapy.Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinopathy (AZOOR) with adalimumab (Humira™).A rare case of peripheral ulcerative keratitis associated with Behçet's disease.Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Behçet's disease.Outcome of Juvenile Idiopathic Arthritis Associated Uveitis in Two Disease Subtypes
P2860

Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology.

Item
http://www.wikidata.org/entity/Q37834466
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adalimumab (Humira™): a promis ...... factor alpha in ophthalmology.
@en
type
label
Adalimumab (Humira™): a promis ...... factor alpha in ophthalmology.
@en
prefLabel
Adalimumab (Humira™): a promis ...... factor alpha in ophthalmology.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Adalimumab (Humira™): a promis ...... factor alpha in ophthalmology.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921